In yesterday’s Wall Street session, Immuneering Corp (NASDAQ:IMRX) shares traded at $2.02, up 41.26% from the previous session.
IMRX stock price is now 71.96% away from the 50-day moving average and -41.10% away from the 200-day moving average. The market capitalization of the company currently stands at $59.89M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $20 to $15, Needham maintained Buy rating for Immuneering Corp (NASDAQ: IMRX). , while ‘Jefferies’ rates the stock as ‘Hold’
In other news, Cormorant Asset Management, LP, 10% Owner sold 400,000 shares of the company’s stock on Apr 01 ’24. The stock was sold for $1,160,181 at an average price of $2.90. Upon completion of the transaction, the 10% Owner now directly owns 2,895,273 shares in the company, valued at $5.85 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 22 ’24, Director Schall Thomas J. bought 2,900 shares of the business’s stock. A total of $7,385 was incurred on buying the stock at an average price of $2.55. This leaves the insider owning 2,900 shares of the company worth $5858.0. A total of 29.16% of the company’s stock is owned by insiders.
During the past 12 months, Immuneering Corp has had a low of $1.00 and a high of $9.00. As of last week, the company has a debt-to-equity ratio of 0.06, a current ratio of 9.39, and a quick ratio of 9.39. The fifty day moving average price for IMRX is $1.1925 and a two-hundred day moving average price translates $3.39995 for the stock.
The latest earnings results from Immuneering Corp (NASDAQ: IMRX) was released for 2024-06-30.
